Trial intelligence / Profile preview

TMC435 plus peginterferon alfa-2a and ribavirin in untreated genotype 1 chronic HCV

CTR20131603Phase 3Completed

Sponsor

Tibotec

Start

Jan 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1